Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100051175> ?p ?o ?g. }
- W2100051175 endingPage "1686" @default.
- W2100051175 startingPage "1677" @default.
- W2100051175 abstract "Quinoxalinehydrazines represent a novel class of compounds with excellent potency in a panel of cancer cell lines. A prototype compound, SC144, showed significant in vivo efficacy in mice xenograft models of human breast cancer cells. The subsequent structure-activity relationship study resulted in the discovery of SC161 with better potency in cancer cell lines. Further exploring the possible conformational space by a 10 ns molecular dynamics simulation as presented herein, resulted in various pharmacophore orientations. The trajectory analysis indicated that in most of the simulation time, the molecule stays favorably in a compact planarlike orientation. We therefore built a pharmacophore model based on the cluster containing the highest number of frames to represent the most probable orientation. The model was used to screen a subset of our small molecule database containing 350,000 compounds. We selected 35 compounds for the initial cytotoxicity screen. Seventeen compounds belonging to oxadiazolopyrazine and quinoline class displayed cytotoxicity in various cancer cell lines. Five of them, compounds 2, 6, 15, 16, and 19, all bearing an oxadiazolopyrazine scaffold, showed IC(50) values <3 muM in certain tumor cell lines. The most potent compound, 2, showed IC(50) values <2 muM in HCT116 p53(+/+), HCT116 p53(-/-), and HEY cells, and 8 muM in NIH3T3 cells. This study shows that conformational sampling of a lead small molecule followed by representative pharmacophore model development is an efficient approach for the rational design of novel anticancer agents with similar or better potency than the original lead but with different physicochemical properties." @default.
- W2100051175 created "2016-06-24" @default.
- W2100051175 creator A5003654269 @default.
- W2100051175 creator A5023220693 @default.
- W2100051175 creator A5042076209 @default.
- W2100051175 creator A5050767033 @default.
- W2100051175 creator A5079076462 @default.
- W2100051175 creator A5082045444 @default.
- W2100051175 date "2008-11-17" @default.
- W2100051175 modified "2023-09-24" @default.
- W2100051175 title "Discovery of Novel Anticancer Compounds Based on a Quinoxalinehydrazine Pharmacophore" @default.
- W2100051175 cites W1972362308 @default.
- W2100051175 cites W1977173978 @default.
- W2100051175 cites W1978949686 @default.
- W2100051175 cites W1987704006 @default.
- W2100051175 cites W1995871595 @default.
- W2100051175 cites W2015341962 @default.
- W2100051175 cites W2020509520 @default.
- W2100051175 cites W2025264200 @default.
- W2100051175 cites W2035687084 @default.
- W2100051175 cites W2041662325 @default.
- W2100051175 cites W2049502419 @default.
- W2100051175 cites W2070414408 @default.
- W2100051175 cites W2072597242 @default.
- W2100051175 cites W2074872461 @default.
- W2100051175 cites W2088616755 @default.
- W2100051175 cites W2092749292 @default.
- W2100051175 cites W2106140689 @default.
- W2100051175 cites W2110265155 @default.
- W2100051175 cites W2118733096 @default.
- W2100051175 cites W2129690138 @default.
- W2100051175 cites W2132712767 @default.
- W2100051175 cites W2157915773 @default.
- W2100051175 cites W2171268876 @default.
- W2100051175 doi "https://doi.org/10.1002/cmdc.200800217" @default.
- W2100051175 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18985651" @default.
- W2100051175 hasPublicationYear "2008" @default.
- W2100051175 type Work @default.
- W2100051175 sameAs 2100051175 @default.
- W2100051175 citedByCount "11" @default.
- W2100051175 countsByYear W21000511752013 @default.
- W2100051175 countsByYear W21000511752018 @default.
- W2100051175 countsByYear W21000511752020 @default.
- W2100051175 countsByYear W21000511752021 @default.
- W2100051175 countsByYear W21000511752022 @default.
- W2100051175 countsByYear W21000511752023 @default.
- W2100051175 crossrefType "journal-article" @default.
- W2100051175 hasAuthorship W2100051175A5003654269 @default.
- W2100051175 hasAuthorship W2100051175A5023220693 @default.
- W2100051175 hasAuthorship W2100051175A5042076209 @default.
- W2100051175 hasAuthorship W2100051175A5050767033 @default.
- W2100051175 hasAuthorship W2100051175A5079076462 @default.
- W2100051175 hasAuthorship W2100051175A5082045444 @default.
- W2100051175 hasConcept C109316439 @default.
- W2100051175 hasConcept C121608353 @default.
- W2100051175 hasConcept C150903083 @default.
- W2100051175 hasConcept C171250308 @default.
- W2100051175 hasConcept C178790620 @default.
- W2100051175 hasConcept C178910836 @default.
- W2100051175 hasConcept C185592680 @default.
- W2100051175 hasConcept C192562407 @default.
- W2100051175 hasConcept C193042331 @default.
- W2100051175 hasConcept C202751555 @default.
- W2100051175 hasConcept C207001950 @default.
- W2100051175 hasConcept C21951064 @default.
- W2100051175 hasConcept C2776309666 @default.
- W2100051175 hasConcept C2777752112 @default.
- W2100051175 hasConcept C2994372470 @default.
- W2100051175 hasConcept C53105671 @default.
- W2100051175 hasConcept C54355233 @default.
- W2100051175 hasConcept C55493867 @default.
- W2100051175 hasConcept C56173144 @default.
- W2100051175 hasConcept C57992300 @default.
- W2100051175 hasConcept C70721500 @default.
- W2100051175 hasConcept C71240020 @default.
- W2100051175 hasConcept C86803240 @default.
- W2100051175 hasConcept C96232424 @default.
- W2100051175 hasConceptScore W2100051175C109316439 @default.
- W2100051175 hasConceptScore W2100051175C121608353 @default.
- W2100051175 hasConceptScore W2100051175C150903083 @default.
- W2100051175 hasConceptScore W2100051175C171250308 @default.
- W2100051175 hasConceptScore W2100051175C178790620 @default.
- W2100051175 hasConceptScore W2100051175C178910836 @default.
- W2100051175 hasConceptScore W2100051175C185592680 @default.
- W2100051175 hasConceptScore W2100051175C192562407 @default.
- W2100051175 hasConceptScore W2100051175C193042331 @default.
- W2100051175 hasConceptScore W2100051175C202751555 @default.
- W2100051175 hasConceptScore W2100051175C207001950 @default.
- W2100051175 hasConceptScore W2100051175C21951064 @default.
- W2100051175 hasConceptScore W2100051175C2776309666 @default.
- W2100051175 hasConceptScore W2100051175C2777752112 @default.
- W2100051175 hasConceptScore W2100051175C2994372470 @default.
- W2100051175 hasConceptScore W2100051175C53105671 @default.
- W2100051175 hasConceptScore W2100051175C54355233 @default.
- W2100051175 hasConceptScore W2100051175C55493867 @default.
- W2100051175 hasConceptScore W2100051175C56173144 @default.
- W2100051175 hasConceptScore W2100051175C57992300 @default.
- W2100051175 hasConceptScore W2100051175C70721500 @default.